mesalamine has been researched along with Fetal Growth Retardation in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Fetal Growth Retardation: Failure of a FETUS to attain expected GROWTH.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Busoni, VB | 1 |
| Lemale, J | 1 |
| Dubern, B | 1 |
| Frangi, F | 1 |
| Bourgeois, P | 1 |
| Orsi, M | 1 |
| Badens, C | 1 |
| Fabre, A | 1 |
1 other study available for mesalamine and Fetal Growth Retardation
| Article | Year |
|---|---|
IBD-Like Features in Syndromic Diarrhea/Trichohepatoenteric Syndrome.
Topics: Anti-Inflammatory Agents; Biological Therapy; Colitis; Colon; Diarrhea; Diarrhea, Infantile; Facies; | 2017 |